[EN] 20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE<br/>[FR] ANTAGONISTES DU RÉCEPTEUR DE 20-HETE (GPR75) ET PROCÉDÉS D'UTILISATION
申请人:UNIV TEXAS
公开号:WO2017156164A1
公开(公告)日:2017-09-14
The present invention concerns compounds and their use to treat cardiovascular disease, renal disease, thrombic disease, stroke, metabolic syndrome, cell proliferation, and ischemic cardiovascular disorders. Compounds of the present invention display significant potency as antagonists of 20-hydroxyeicosatetraenoic acid (20-HETE), and function as anti-hypertensive, anti-inflammatory, or anti-growth agents.
本发明涉及化合物及其用于治疗心血管疾病、肾脏疾病、血栓性疾病、中风、代谢综合征、细胞增殖和缺血性心血管疾病的用途。本发明的化合物作为20-羟基二十碳四烯酸(20-HETE)拮抗剂显示出显著的效力,并作为抗高血压、抗炎症或抗生长剂。